Clinical trials
Recruiting Recurrence trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 5 |
| AstraZeneca | 3 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
| Kiniksa Pharmaceuticals International, plc | 2 |
| Université de Sherbrooke | 2 |
| AHS Cancer Control Alberta | 1 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Abraham Nunes | 1 |
| Arvinas Inc. | 1 |
| Australian & New Zealand Children's Haematology/Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 39 |
| Multiple Myeloma | 7 |
| Glioblastoma | 4 |
| Lymphoma | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Neoplasms | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Cytokine Release Syndrome | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.